Northwest Biotherapeutics, Inc. (NWBO)

USD 0.21

(-1.87%)

Revenue Summary of Northwest Biotherapeutics, Inc.

  • Northwest Biotherapeutics, Inc.'s latest annual revenue in 2023 was 1.93 Million USD , up 14.8% from previous year.
  • Northwest Biotherapeutics, Inc.'s latest quarterly revenue in 2024 Q2 was 510 Thousand USD , up 79.58% from previous quarter.
  • Northwest Biotherapeutics, Inc. reported a annual revenue of 1.68 Million USD in annual revenue 2022, up 67.46% from previous year.
  • Northwest Biotherapeutics, Inc. reported a annual revenue of 1 Million USD in annual revenue 2021, down -22.15% from previous year.
  • Northwest Biotherapeutics, Inc. reported a quarterly revenue of 510 Thousand USD for 2024 Q2, up 79.58% from previous quarter.
  • Northwest Biotherapeutics, Inc. reported a quarterly revenue of 201 Thousand USD for 2023 Q2, down -77.16% from previous quarter.

Annual Revenue Chart of Northwest Biotherapeutics, Inc. (2023 - 1996)

Historical Annual Revenue of Northwest Biotherapeutics, Inc. (2023 - 1996)

Year Revenue Revenue Growth
2023 1.93 Million USD 14.8%
2022 1.68 Million USD 67.46%
2021 1 Million USD -22.15%
2020 1.29 Million USD -46.43%
2019 2.41 Million USD 484.95%
2018 412 Thousand USD 22.62%
2017 336 Thousand USD -46.07%
2016 623 Thousand USD -64.17%
2015 1.73 Million USD 19.6%
2014 1.45 Million USD 79.73%
2013 809 Thousand USD 4.79%
2012 772 Thousand USD 7620.0%
2011 10 Thousand USD 0.0%
2010 10 Thousand USD 0.0%
2009 10 Thousand USD 0.0%
2008 10 Thousand USD 0.0%
2007 10 Thousand USD -98.75%
2006 800 Thousand USD 545.16%
2005 124 Thousand USD -68.21%
2004 390 Thousand USD -26.28%
2003 529 Thousand USD 5777.78%
2002 9000.00 USD -93.05%
2001 129.44 Thousand USD -17.0%
2000 155.96 Thousand USD -25.73%
1999 210 Thousand USD -46.15%
1998 390 Thousand USD -18.75%
1997 480 Thousand USD 108.7%
1996 230 Thousand USD 0.0%

Peer Revenue Comparison of Northwest Biotherapeutics, Inc.

Name Revenue Revenue Difference
Burzynski Research Institute, Inc. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD -2451.371%
Evofem Biosciences, Inc. 18.21 Million USD 89.395%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 98.429%
Qrons Inc. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Skye Bioscience, Inc. - USD -Infinity%
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 87.751%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -10864.19%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 21.47 Million USD 91.005%
Intellipharmaceutics International Inc. 65.72 Thousand USD -2839.387%
Propanc Biopharma, Inc. - USD -Infinity%
Mesoblast Limited 5.9 Million USD 67.265%
Marizyme, Inc. 645.81 Thousand USD -199.159%
Genus plc 668.8 Million USD 99.711%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.212%
Therapeutic Solutions International, Inc. 98.99 Thousand USD -1851.633%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD -371.03%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -2416.903%
IMV Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -4788.911%
MultiCell Technologies, Inc. 49.32 USD -3917174.939%
ONE Bio Corp. 52.29 Million USD 96.306%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 96.114%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. 48.9 Thousand USD -3850.92%
Q BioMed Inc. 284.35 Thousand USD -579.44%
Emmaus Life Sciences, Inc. 29.59 Million USD 93.472%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 98.669%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD -246.417%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. 70 Thousand USD -2660.0%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD -193.394%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 14.69 Billion USD 99.987%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 999.00 USD -193293.393%
Enzolytics Inc. 52.79 Thousand USD -3559.368%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 608.52 Thousand USD -217.489%
MetaStat, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 99.842%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. 140.24 Thousand USD -1277.619%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD -212.933%
Zenith Capital Corp. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 99.77%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD -93.64%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 48.35 Million USD 96.004%
BioStem Technologies, Inc. 16.68 Million USD 88.421%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD -716.706%
Regen BioPharma, Inc. 236.56 Thousand USD -716.706%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. 1.36 Million USD -41.125%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD -307.827%
SYBLEU INC 11.69 Thousand USD -16418.468%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 75.196%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -14761.538%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -4786.933%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 41.982%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 71.013%
IntelGenx Technologies Corp. 1.03 Million USD -85.948%
Gelesis Holdings, Inc. 25.76 Million USD 92.502%
CSL Limited 14.8 Billion USD 99.987%
Cellectis S.A. 755 Thousand USD -155.894%